EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Cachexia in gynecologic cancers: The role of biomarkers and cachexia index

Saroj Rajan iD, Ekta Dhamija, Neena Malhotra, Deepak Vats, Archana Singh, Seema Singhal iD

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70262 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Saroj Rajan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Cachexia, Activins, Genital Neoplasms, Female. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer cachexia, a metabolic syndrome causing muscle loss, inflammation, and malnutrition, adversely affects prognosis and treatment in cancer patients. Despite extensive studies in other malignancies, cachexia remains underexplored in gynecologic cancers, particularly in India. This study evaluates the cachexia index (CXI) in gynecologic cancer patients and its association with Activin A and Myostatin.

Methods

In this prospective observational study, 160 women with gynecologic malignancies were assessed for cachexia using Fearon's criteria, the global leadership initiative on malnutrition (GLIM) definition, and CXI, which integrates skeletal muscle index (SMI), albumin, and neutrophil‐to‐lymphocyte ratio (NLR). Serum Activin A and Myostatin were measured via enzyme‐linked immunosorbent assay. A subgroup of 30 ovarian cancer patients received nutritional and physical prehabilitation, with biomarker reassessment post‐intervention.

Results

Cachexia prevalence was 22.50% (Fearon's) and 56.25% (GLIM). The median CXI was 56.74, with 33.75% having CXI < 41, indicating severe cachexia. CXI < 41 was correlated with advanced disease ( P = 0.000), lower body mass index ( P = 0.034), reduced SMI ( P = 0.000), and elevated inflammatory markers. Activin A was significantly higher in severe cachexia ( P = 0.024), while Myostatin showed no correlation. Prehabilitation significantly improved CXI ( P = 0.0001) and reduced Activin A and Myostatin ( P = 0.0003, P < 0.0001). In multivariable analysis, platelet‐to‐lymphocyte ratio emerged as the only independent predictor of low CXI (odds ratio 1.0145; 95% confidence interval 1.0081–1.0210; P < 0.001), while Activin A showed a trend toward significance ( P = 0.088).

Conclusion

CXI provides a comprehensive cachexia assessment in gynecologic cancers. Elevated Activin A is linked to muscle degradation. Prehabilitation improves CXI and reduces cachexia biomarkers, emphasizing its therapeutic potential. Further validation of CXI and biomarkers may enhance cachexia diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaActivinsGenital Neoplasms, FemaleHumansFemaleMiddle AgedProspective StudiesMyostatinBiomarkersAdultAgedIndiaBody Mass IndexMuscle, SkeletalSeverity of Illness IndexPrevalenceNeutrophils

Stichwörter der Autor:innen

Activin Acachexiafemale genital neoplasmsmyostatinprehabilitationsarcopenia

Substanzen

Activinsactivin AMyostatinBiomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.

ORCID-Profile: Saroj Rajan, Seema Singhal

Zitieren

APA

Rajan, S., Dhamija, E., Malhotra, N., Vats, D., Singh, A., & Singhal, S. (2025). Cachexia in gynecologic cancers: The role of biomarkers and cachexia index. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70262

Vancouver

Rajan S, Dhamija E, Malhotra N, Vats D, Singh A, Singhal S. Cachexia in gynecologic cancers: The role of biomarkers and cachexia index. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70262

BibTeX
@article{Rajan2025,
  author = {Rajan, Saroj and Dhamija, Ekta and Malhotra, Neena and Vats, Deepak and Singh, Archana and Singhal, Seema},
  title = {Cachexia in gynecologic cancers: The role of biomarkers and cachexia index},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70262}
}
Kostenlos starten →